NEW YORK, March 7 - Durham, NC-based startup Expression Analysis will provide gene chip processing services for the Duke University Medical Center, the company said on Thursday.
Expression Analysis will provide statistical analysis and laboratory services for Duke researchers using Affymetrix microarrays. The company will process and hybridize Duke's RNA samples and also undertake target-probe development.
Financial details of the arrangement were not disclosed.
This agreement will be overseen by Holly Dressman, who directs the microarray facility at Duke University Medical Center. The project director is EA chief of genomic sciences Laura Reid, who was previously director of the microarray facility at the University of North Carolina in Chapel Hill.
EA has close ties to Duke: three of its scientific advisory board members are Duke researchers, and the company's chief operating officer, Steven Casey, was formerly a Howard Hughes administrator at Duke.
Casey said in a statement that this outsourcing arrangement will allow Duke to reduce overhead. The company hopes to become a primary service providers for Affymetrix products, and offer low-cost gene chip analysis to academics, biotech companies and government researchers.
Expression Analysis was launched earlier this year by Analytical Sciences, a Durham contract research organization.